Biểu đồ giá cổ phiếu DHTRF
DHTRF Thu nhập
Dri Healthcare Trust
$12.7
-0.78%
$-0.1
Khi đóng cửa: Jun 22, 16:00:00 GMT-4
$12.7
0%
$0
Phiên sau giờ: Jun 22, 20:00:00 GMT-4
Quay lại
Dri Healthcare Trust (DHTRF) Thu nhập
Thống kê chính
Giá đóng cửa trước
$12.8
Giá mở cửa
$12.7
Phạm vi ngày
$12.7 - $12.7
Phạm vi 52 tuần
$9.55 - $13.27
Khối lượng
--
Khối lượng trung bình
10.5K
Tỷ suất cổ tức
--
EPS (TTM)
-0.90
Vốn hóa thị trường
$698.7M
DRI HEALTHCARE TR là gì?
DRI Healthcare Trust is an unincorporated open-ended company. The firm's portfolio consists of 29 royalty streams on 23 products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. Its Royalty Assets include Ekterly, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Vonjo I, Vonjo II, Xolair, Zejula, Zytiga, and others. The Ekterly is an oral on-demand therapy for treating attacks associated with Hereditary Angioedema (HAE). The Eylea I is a vascular endothelial growth factor inhibitor initially indicated for the treatment of neovascular wet age-related macular degeneration. Natpara is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.
